| 英文名称 |
中文名称 |
CAS |
|
methyl (4R)-4-[(5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate
|
3-Oxo-7α-hydroxy-5β-cholan-24-oic acid methyl ester |
14773-00-3 |
|
(S)-[(1S,2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](quinolin-4-yl)methanol
|
辛可宁 |
118-10-5 |
|
Canagliflozin
|
卡格列净 |
842133-18-0 |
|
Ipragliflozin
|
伊格列净 |
761423-87-4 |
|
EPZ-015666
|
EPZ015666 |
1616391-65-1 |
|
(2S,3S)-2,3-bis(benzoyloxy)butanedioic acid; (3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
|
鲁索利替尼中间体 |
1236033-04-7 |
|
Zamicastat
|
Zamicastat |
1080028-80-3 |
|
Clemastine fumarate
|
富马酸氯马斯汀 |
14976-57-9 |
|
(-)-Epicatechin
|
表儿茶素 |
490-46-0 |
|
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide
|
利巴韦林 |
36791-04-5 |
|
Tofacitinib
|
托法替尼 |
477600-75-2 |
|
(+)-Tetrabenazine
|
(3R,11BR)-1,3,4,6,7,11B-六氢-9,10-二甲氧基-3-异丁基-2H-苯并[A]喹嗪-2-酮 |
1026016-83-0 |
|
Lenvatinib
|
乐伐替尼 |
417716-92-8 |
|
Ibrutinib
|
依鲁替尼 |
936563-96-1 |
|
Ponatinib
|
帕纳替尼 |
943319-70-8 |
|
PF-06840003
|
3-(5-氟-1H-吲哚-3-基)-2,5-吡咯烷二酮 |
198474-05-4 |
|
TCMDC 123865
|
特拉唑嗪杂质E |
102839-00-9 |
|
AP26113
|
AP26113 |
1197958-12-5 |
|
AZD-5363
|
4-氨基-N-[(1S)-1-(4-氯苯基)-3-羟基丙基]-1-(7H-吡咯并[2,3-D]嘧啶-4-基)-4-哌啶甲酰胺 |
1143532-39-1 |
|
MK 0657
|
化合物 T12733 |
808732-98-1 |
|
N-[cis-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]cyclobutyl]propane-1-sulfonamide
|
PF-04965842(阿布罗替尼) |
1622902-68-4 |
|
Aficamten
|
AFICAMTEN |
2364554-48-1 |
|
Tadalafil
|
他达拉非 |
171596-29-5 |
|
Ertugliflozin
|
埃格列净 |
1210344-57-2 |
|
Rociletinib
|
CO1686 |
1374640-70-6 |
|
Acalabrutinib
|
阿卡替尼 |
1420477-60-6 |
|
E-7046
|
E-7046 |
1369489-71-3 |
|
Reldesemtiv
|
CK-2127107 |
1345410-31-2 |
|
Benztropine mesylate
|
苯扎托品 |
132-17-2 |
|
Ivacaftor
|
依伐卡托 |
873054-44-5 |
|
Cobimetinib
|
考比替尼 |
934660-93-2 |
|
BAY-41-8543
|
BAY-41-8543 |
256498-66-5 |
|
PRT 062607
|
化合物 T24584 |
1370261-98-5 |
|
CLP 290
|
2{[(5Z)2(1,2diazinan1yl)4oxo4,5dihydro1,3thiazol5ylidene]Methyl}5fluorophenyl pyrrolidine1carboxylate |
1181083-81-7 |
|
4-hydroxy-2-methoxy-benzaldehyde
|
4-羟基-2-甲氧基苯甲醛 |
18278-34-7 |
|
Riluzole
|
利鲁唑 |
1744-22-5 |
|
tert-butyl 2-[(5-fluoro-2-pyridyl)oxymethyl]-8-azabicyclo[3.2.1]octane-8-carboxylate
|
2-((((5-氟吡啶-2-基)氧基)甲基)-8-氮杂双环[3.2.1]辛烷-8-羧酸叔丁酯 |
2007919-75-5 |
|
PF-06882961
|
PF-06882961 |
2230198-02-2 |
|
Lopinavir
|
洛匹那韦 |
192725-17-0 |
|
(2R,3R,4R)-3,4-bis(acetyloxy)-3,4-dihydro-2H-pyran-2-yl]methyl acetate
|
D-三乙酰半乳糖烯 |
4098-06-0 |
|
tasimelteon
|
他司美琼 |
609799-22-6 |
|
Telaprevir
|
特拉匹韦（VX-950） |
402957-28-2 |
|
2-[4-(3-methylpyrazin-2-yl)phenyl]-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide
|
TTA-A8 |
1146395-46-1 |
|
Gemcitabine
|
吉西他滨 |
95058-81-4 |
|
OWL 833
|
GLP-1 receptor agonist 1 |
2212020-52-3 |
|
sotagliflozin
|
索格列净 |
1018899-04-1 |
|
1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyl-oxiran-2-yl]methyl]-1,2,4-triazole
|
1-(((2R,3S)-2-(2,4-二氟苯基)-3-甲基环氧乙基-2-基)甲基)-1H-1,2,4-三唑 |
127000-90-2 |
|
Empagliflozin
|
恩格列净 |
864070-44-0 |
|
Enasidenib
|
恩西地平 |
1446502-11-9 |
|
AQW-051
|
AQW-051 |
669770-29-0 |
|
GS 5734
|
瑞德西韦 |
1809249-37-3 |
|
ABBV-744
|
ABBV-744 |
2138861-99-9 |
|
Tetrabenazine
|
丁苯那嗪 |
58-46-8 |
|
SB-431542
|
SB-431542 |
301836-41-9 |
|
Riociguat
|
利奥西呱 |
625115-55-1 |
|
Enzalutamide
|
恩杂鲁胺 |
915087-33-1 |
|
Alectinib
|
艾乐替尼 |
1256580-46-7 |
|
6-amino-4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-7-ethoxyquinoline-3-carbonitrile
|
6-氨基-4-(3-氯-4-(吡啶-2-取代甲氧基)苯胺)-7-乙氧基喹啉-3-甲腈 |
848139-78-6 |
|
Vortioxetine
|
沃替西汀 |
508233-74-7 |
|
Siponimod
|
辛波莫德 |
1230487-00-9 |
|
Lumateperone
|
卢美哌隆 |
313368-91-1 |
|
PF-06650833
|
PF-06650833 |
1817626-54-2 |
|
Risdiplam
|
利司扑兰 |
1825352-65-5 |
|
(1R)-6-fluoro-7-(2-fluoro-6-hydroxy-phenyl)-1-(2-isopropyl-4-methyl-3-pyridyl)-4-[(2S)-2-methyl-4-prop-2-enoyl-piperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one
|
AMG510 单一构型 |
2296729-00-3 |
|
PLX-4720
|
N-[3-[(5-氯-1H-吡咯并[2,3-B]吡啶-3-基)羰基]-2,4-二氟苯基]-1-丙磺酰胺 |
918505-84-7 |
|
GW-2580
|
GW2580 |
870483-87-7 |
|
pilaralisib
|
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 |
934526-89-3 |
|
GSK-356278
|
GSK-356278 |
720704-34-7 |
|
(Z)-4-amino-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide
|
4-氨基-N-(3-溴-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 |
914638-30-5 |
|
ON-123300
|
8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 |
1357470-29-1 |
|
N-(cyclopropanesulfonyl)-4,4-dimethyl-2-[3-(morpholin-4-yl)phenyl]-1,2,3,4-tetrahydroquinoline-6-carboxamide
|
N-(cyclopropanesulfonyl)-4,4-dimethyl-2-[3-(morpholin-4-yl)phenyl]-1,2,3,4-tetrahydroquinoline-6-carboxamide |
1391608-77-7 |
|
3-[[3-(cyclopropylsulfamoyl)-7-(2,4-dimethoxypyrimidin-5-yl)-4-quinolyl]amino]-5-(3,5-difluorophenoxy)benzoic acid
|
1445879-21-9 |
1445879-21-9 |
|
(3S,8S,9S,10R,13R,14S,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
|
胆固醇 |
57-88-5 |
|
Encenicline enantiomer
|
|
550999-76-3 |
|
Macitentan
|
马西替坦 |
441798-33-0 |
|
kd-025
|
2-[3-[4-[(1H-吲唑-5-基)氨基]喹唑啉-2-基]苯氧基]-N-异丙基乙酰胺 |
911417-87-3 |
|
PF-04447943
|
PF 4447943 |
1082744-20-4 |
|
N-[2-[(3S)-3-[[cis-4-hydroxy-4-(5-pyrimidin-2-yl-2-pyridyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxo-ethyl]-3-(trifluoromethyl)benzamide
|
N-(2 - ((S)-3 - (((1R,4S)-4-羟基-4-(5-(嘧啶-2-基)吡啶-2-基)环己基)氨基)吡咯烷-1-基)-2-氧代乙基)-3-(三氟甲基)苯甲酰胺 |
1372407-07-2 |
|
4-[[(2S,3R,4R,5S)-3-(3,4-difluoro-2-methoxy-phenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carbonyl]amino]pyridine-2-carboxamide
|
|
2649467-57-0 |
|
3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide
|
化合物INAXAPLIN |
2446816-88-0 |
|
N-[(2-methyl-4-{2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}phenyl)methyl]-3-(propan-2-yloxy)azetidine-1-carboxamide
|
BIIB068 |
1798787-27-5 |
|
N-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3S)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-3-yl)pyridine-3-carboxamide
|
N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3S)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-3-yl)pyridine-3-carboxamide |
1492952-73-4 |
|
2-bromo-1-[(3R,5R,8R,9R,10S,13S,14S,17S)-3-hydroxy-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone
|
2-溴-1-((3R,5R,8R,9R,10S,13S,14S,17S)-3-羟基-3,13-二甲基十六氢-1H-环戊二烯并[A]菲-17-基)乙酮 |
1430063-93-6 |
|
BLU-9931
|
BLU 9931 |
1538604-68-0 |
|
SP-13786
|
(S)-N-[2-(2-氰基-4,4-二氟-1-吡咯烷基)-2-氧代乙基]喹啉-4-甲酰胺 |
1448440-52-5 |
|
PD-126055 free acid
|
EMA401 |
1316755-16-4 |
|
6-fluoro-3-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-indole
|
|
1802154-20-6 |
|
(1S)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-4-[(2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-Pyrido[2,3-d]pyrimidin-2(1H)-one
|
AMG-510 轴手性异构体(P-/S-) |
2296729-66-1 |
|
pimavanserin
|
匹莫范色林 |
706779-91-1 |
|
Dapagliflozin
|
达格列净 |
461432-26-8 |
|
methyl (4R)-4-[(7R,8S,9S,10R,13R,14S,17R)-7-(methoxymethoxy)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoate
|
(R)-4-[(7R,8S,9S,10R,13R,14S,17R)-7-(甲氧基甲氧基)-10,13-二甲基-3-氧代-2,3,6,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊并[A]菲-17-基]戊酸甲酯 |
610313-90-1 |
|
Virgaureagenin B
|
齐墩果酸 |
508-02-1 |
|
flibanserin
|
氟立班丝氨 |
167933-07-5 |
|
Avanafil
|
阿伐那非 |
330784-47-9 |
|
Telotristat ethyl
|
特罗司他乙酯 |
1033805-22-9 |
|
(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
|
胆酸 |
81-25-4 |
|
Lifitegrast
|
立他司特 |
1025967-78-5 |
|
erlotinib
|
埃罗替尼 |
183321-74-6 |
|
Tamoxifen
|
他莫昔芬 |
10540-29-1 |
|
BC-1382
|
|
2197231-02-8 |
